Fulton Bank’s Dr. Reddy's Laboratories RDY Stock Holding History

Fulton Bank’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,315	Closed	-$205K	–	444
2020 Q2	$205K	Buy	+19,315	New	+$196K	0.01%	395

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fulton Bank's RDY Position: Q3 2020 in Review

Fulton Bank sold out of Dr. Reddy's Laboratories (RDY) in Q3 2020, closing a stake of 19,315 shares — an estimated $205K sold.

Fulton Bank first reported a position in RDY in Q2 2020 and held it in 1 quarter. The position peaked at $205K in Q2 2020. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

Fulton Bank reported no remaining Dr. Reddy's Laboratories position as of Q3 2020 after selling out during the quarter.
Fulton Bank sold 19,315 Dr. Reddy's Laboratories shares in Q3 2020, an estimated $205K.
Fulton Bank first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 1 quarter.
Fulton Bank's Dr. Reddy's Laboratories position peaked at $205K in Q2 2020.
186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on Fulton Bank's 13F filing for Q3 2020, filed 6 Oct 2020.